AI Article Synopsis
Article Abstract
Objectives: The HFA-PEFF score has been validated to hold great diagnostic and prognostic utility for heart failure with preserved ejection fraction (HFpEF). Idiopathic inflammatory myopathy (IIM) is recognized as one of the potential etiologies underlying HFpEF. Here, we intended to investigate the real prevalence of HFpEF in IIM via the HFA-PEFF score and explore the prognostic value of this score.
Methods: Two hundred twenty IIM patients were enrolled for assessment. The cohort was divided into low, intermediate and high tertiles of the HFA-PEFF score. Spearman's correlation analysis was used to explore the association between the score and disease activity. Chi-square test was applied to investigate the distribution discrepancy of HFA-PEFF tertiles among patients with different myositis-specific antibodies (MSAs) or myositis-associated antibodies (MAAs). Univariate and multivariate ordinal regression analyses were performed to screen risk factors for high HFA-PEFF scores. Survival curves were obtained using the Kaplan-Meier method and log-rank tests.
Results: In total, 79 (35.9%), 107 (48.6%) and 34 (15.5%) patients were rated low, intermediate and high probability of HFpEF, respectively. The HFA-PEFF score correlated well with disease activity. Patients with positive AMA-M2 scored higher in the HFA-PEFF score (p = 0.011). During follow-up, patients with positive AMA-M2 or anti-SRP antibody developed an inclination towards concentric hypertrophy on echocardiography. Additionally, palpitation symptom, AMA-M2 positivity and elevated serum levels of LDH, cTnI were independent risk factors for high HFA-PEFF scores. Finally, a high-tertile HFA-PEFF score was related to lower overall survival rate (p < 0.001). Patients with positive AMA-M2 had poorer outcomes (p = 0.002).
Conclusion: HFpEF was prevailing in IIM patients according to the HFA-PEFF score. The HFA-PEFF score correlated well with disease activity and held significant prognostic value. Patients with AMA-M2 antibody were prone to have poor outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401815 | PMC |
| http://dx.doi.org/10.1186/s13075-023-03131-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Follow-Up Study of Percutaneous Intramyocardial Septal Radiofrequency Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy With HFpEF.
Echocardiography
November 2024
Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Background: The study aimed to evaluate the changes of left ventricular diastolic function and the improvement of clinical symptoms in hypertrophic cardiomyopathy (HCM) patients with heart failure with preserved ejection fraction (HFpEF) after percutaneous intramyocardial septal radiofrequency ablation (PIMSRA).
Methods: This study enrolled 31 adult HCM patients with HFpEF who underwent PIMSRA treatment. Electrocardiogram, imaging, and blood biochemical examinations were performed on these patients during a 6-month follow-up.
Is sinus rhythm maintenance after repeat catheter ablation effective in patients with atrial fibrillation and heart failure with preserved ejection fraction?
J Cardiovasc Electrophysiol
December 2024
Division of Cardiology, Osaka Rosai Hospital, Sakai, Osaka, Japan.
Article Synopsis
- Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are associated with serious health risks, but maintaining sinus rhythm (SR) post-catheter ablation (CA) has shown benefits over standard medical treatment.
- A study of 244 AF patients with HFpEF compared outcomes between those maintaining SR after their first CA and those after a repeat CA, finding similar rates of adverse health events over three years.
- The results indicate that maintaining SR after a repeat CA does not offer additional benefits compared to maintaining SR after the initial CA, suggesting both approaches are equally effective in managing these patients.
Heart Failure with Preserved Ejection Fraction Correlates with Fibrotic Atrial Myopathy in Patients Undergoing Atrial Fibrillation Ablation.
J Clin Med
September 2024
Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.
The incidence of atrial fibrillation (AF) in patients with heart failure with preserved ejection fraction (HFpEF) is high. Impaired left atrial (LA) function is a major determinant in HFpEF. However, the extent of electrical LA tissue degeneration in HFpEF is unknown.
View Article and Find Full Text PDFAssociation between postprocedural echocardiographic and laboratory data and clinical outcomes in patients with preserved ejection fraction after catheter ablation for atrial fibrillation.
Heart Rhythm
September 2024
Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
Article Synopsis
- - A simplified AF-HFA-PEFF score was developed to enhance the practicality of diagnosing heart failure in patients with atrial fibrillation, focusing specifically on AF-related factors.
- - The study analyzed 354 patients who underwent catheter ablation, using various echocardiographic and lab data to create and validate this new score.
- - Results showed that the AF-HFA-PEFF score effectively predicts the risk of cardiovascular events and AF recurrence, demonstrating comparable predictive ability to the original HFA-PEFF score but with fewer complexities.
The Oxygen Cascade According to HFpEF Likelihood: A Focus on Sex Differences.
JACC Adv
July 2024
Department of Cardiology, JESSA Hospital, Hasselt, Belgium.
Background: Women are at greater risk for heart failure with preserved ejection fraction (HFpEF).
Objectives: The aim of the study was to compare sex differences in the pathophysiology of exertional breathlessness in patients with high vs low HFpEF likelihood.
Methods: This cohort study evaluated consecutive patients (n = 1,936) with unexplained dyspnea using cardiopulmonary exercise testing and simultaneous echocardiography and quantified peak oxygen uptake (peak VO) and its determinants.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!